Latin America & the Caribbean (IDA & IBRD countries) | Immunization, HepB3 (% of one-year-old children)
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Latin America & the Caribbean (IDA & IBRD countries)
Records
63
Source
Latin America & the Caribbean (IDA & IBRD countries) | Immunization, HepB3 (% of one-year-old children)
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
0 1985
0 1986
0 1987
0 1988
0 1989
0 1990
0 1991
0 1992
0 1993
1.2463351 1994
8.69180375 1995
12.12452463 1996
9.07826519 1997
11.72155802 1998
35.90262127 1999
64.77071919 2000
67.87551188 2001
72.90384693 2002
82.27393902 2003
84.81941128 2004
90.27921676 2005
91.47775774 2006
90.68505112 2007
89.74719936 2008
92.05823698 2009
90.26081785 2010
91.0490535 2011
91.70259664 2012
89.41755237 2013
88.74392768 2014
87.38336581 2015
86.99893559 2016
78.62777297 2017
79.02680953 2018
74.45359439 2019
76.29465807 2020
75.09543052 2021
78.6867336 2022
Latin America & the Caribbean (IDA & IBRD countries) | Immunization, HepB3 (% of one-year-old children)
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Latin America & the Caribbean (IDA & IBRD countries)
Records
63
Source